News about "adMare BioInnovations"

BELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations

BELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations

BELLUS Health Inc.is pleased to announce that it has closed the transaction announced on March 23, 2020 in accordance with the asset purchase and sale agreement entered into with adMare BioInnovations’ NEOMED Institute

AdMare BioInnovations | 27/03/2020 | By Darshana 356


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members